SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Metzger Marie) srt2:(2015-2019)"

Sökning: WFRF:(Metzger Marie) > (2015-2019)

  • Resultat 1-6 av 6
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • 2019
  • Tidskriftsartikel (refereegranskat)
  •  
2.
  •  
3.
  • Cooper, Ian R., et al. (författare)
  • Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors
  • 2016
  • Ingår i: Bioorganic & Medicinal Chemistry Letters. - : Elsevier BV. - 0960-894X .- 1464-3405. ; 26:17, s. 4179-4183
  • Tidskriftsartikel (refereegranskat)abstract
    • There is an urgent and unmet medical need for new antibacterial drugs that tackle infections caused by multidrug-resistant (MDR) pathogens. During the course of our wider efforts to discover and exploit novel mechanism of action antibacterials, we have identified a novel series of isothiazolone based inhibitors of bacterial type II topoisomerase. Compounds from the class displayed excellent activity against both Gram-positive and Gram-negative bacteria with encouraging activity against a panel of MDR clinical Escherichia coli isolates when compared to ciprofloxacin. Representative compounds also displayed a promising in vitro safety profile.
  •  
4.
  • Diaz, Sandra, et al. (författare)
  • The IPBES Conceptual Framework - connecting nature and people
  • 2015
  • Ingår i: Current Opinion in Environmental Sustainability. - : Elsevier BV. - 1877-3435 .- 1877-3443. ; 14, s. 1-16
  • Tidskriftsartikel (refereegranskat)abstract
    • The first public product of the Intergovernmental Platform on Biodiversity and Ecosystem Services (IPBES) is its Conceptual Framework. This conceptual and analytical tool, presented here in detail, will underpin all IPBES functions and provide structure and comparability to the syntheses that IPBES will produce at different spatial scales, on different themes, and in different regions. Salient innovative aspects of the IPBES Conceptual Framework are its transparent and participatory construction process and its explicit consideration of diverse scientific disciplines, stakeholders, and knowledge systems, including indigenous and local knowledge. Because the focus on co-construction of integrative knowledge is shared by an increasing number of initiatives worldwide, this framework should be useful beyond IPBES, for the wider research and knowledge-policy communities working on the links between nature and people, such as natural, social and engineering scientists, policy-makers at different levels, and decision-makers in different sectors of society.
  •  
5.
  • Gorski, Mathias, et al. (författare)
  • 1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function.
  • 2017
  • Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 7
  • Tidskriftsartikel (refereegranskat)abstract
    • HapMap imputed genome-wide association studies (GWAS) have revealed >50 loci at which common variants with minor allele frequency >5% are associated with kidney function. GWAS using more complete reference sets for imputation, such as those from The 1000 Genomes project, promise to identify novel loci that have been missed by previous efforts. To investigate the value of such a more complete variant catalog, we conducted a GWAS meta-analysis of kidney function based on the estimated glomerular filtration rate (eGFR) in 110,517 European ancestry participants using 1000 Genomes imputed data. We identified 10 novel loci with p-value < 5 × 10(-8) previously missed by HapMap-based GWAS. Six of these loci (HOXD8, ARL15, PIK3R1, EYA4, ASTN2, and EPB41L3) are tagged by common SNPs unique to the 1000 Genomes reference panel. Using pathway analysis, we identified 39 significant (FDR < 0.05) genes and 127 significantly (FDR < 0.05) enriched gene sets, which were missed by our previous analyses. Among those, the 10 identified novel genes are part of pathways of kidney development, carbohydrate metabolism, cardiac septum development and glucose metabolism. These results highlight the utility of re-imputing from denser reference panels, until whole-genome sequencing becomes feasible in large samples.
  •  
6.
  • Wagner, Sandra, et al. (författare)
  • Oxidized LDL, statin use, morbidity, and mortality in patients receiving maintenance hemodialysis
  • 2017
  • Ingår i: Free radical research. - : Taylor & Francis. - 1071-5762 .- 1029-2470. ; 51:1, s. 14-23
  • Tidskriftsartikel (refereegranskat)abstract
    • Statin treatment reduces the risk of cardiovascular mortality in the general population, but it has little or no benefit in hemodialyzed (HD) patients. This may reflect different underlying pathophysiology of cardiovascular disease (CVD) in patients treated with HD, maybe involving the oxidative stress. Our aim was to assess the association of oxidized low-density lipoprotein (oxLDL), determined by Mercodia oxLDL enzyme-linked immunosorbent assay (ELISA) kit, with major adverse cardiac events (MACE) and all-cause mortality in HD patients based on the AURORA trial (rosuvastatin vs placebo), and patients not on HD from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. We also assessed whether its decrease due to statin use improves these outcomes using Cox proportional hazard models. Baseline oxLDL level was 34.2 +/- 13.8 U/L in AURORA and did not differ between treatment groups, and 74.6 +/- 28.1 U/L in LURIC. Lower baseline oxLDL levels were associated with higher hazard ratios (HRs) for outcomes, but not anymore after adjusting for apolipoprotein B level in AURORA and was not related to mortality in LURIC. OxLDL levels decreased by 30.9% between baseline and 3 months in the statin-treated group and increased by 10.5% between 3 and 12 months. Nevertheless, oxLDL reduction was not significantly associated with adjusted HRs for MACE and for all-cause mortality. These results showed no association between oxLDL and MACE after adjustment on apolipoprotein B, which may relate to the properties of the method used for oxLDL. Our results also showed no benefit for oxLDL reduction by rosuvastatin on outcomes. Future clinical trials are needed to define the relative CVD risks and benefits of other modalities of oxidative stress modification in this population.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-6 av 6
Typ av publikation
tidskriftsartikel (6)
Typ av innehåll
refereegranskat (5)
populärvet., debatt m.m. (1)
Författare/redaktör
Christophers, Brett (1)
Diaz, Sandra (1)
Kelly, Daniel (1)
Grundström, Karin (1)
Bengtsson-Palme, Joh ... (1)
Abarkan, Abdellah (1)
visa fler...
Andersson, Roger (1)
Baeten, Guy (1)
Clark, Eric (1)
Franzén, Mats (1)
Gabrielsson, Cathari ... (1)
Glad, Wiktoria (1)
Haas, Tigran (1)
Hellström, Björn (1)
Hellström Reimer, Ma ... (1)
Henriksson, Greger (1)
Holgersen, Ståle (1)
Kärrholm, Mattias (1)
Lindholm, Gunilla (1)
Listerborn, Carina (1)
Mack, Jennifer (1)
Magnusson, Jesper (1)
Mattsson, Helena (1)
Metzger, Jonathan (1)
Molina, Irene (1)
Nylander, Ola (1)
Nylund, Katarina (1)
Olsson, Lina (1)
Rizzo, Agatino (1)
Rohracher, Harald (1)
Salonen, Tapio (1)
Schalk, Meike (1)
Schmidt, Staffan (1)
Stenberg, Erik (1)
Stenberg, Jenny (1)
Tesfahuney, Mekonnen (1)
Urban, Susanne (1)
Werner, Inga Britt (1)
Westerdahl, Stig (1)
Öjehag-Pettersson, A ... (1)
Byerley, Andrew (1)
Karvonen, Andy (1)
Legby, Ann (1)
Braide, Anna (1)
Johansson, Britt-Mar ... (1)
Yigit Turan, Burcu (1)
Dyrssen, Catharina (1)
Thörn, Catharina (1)
Mukhtar-Landgren, Da ... (1)
Koch, Daniel (1)
visa färre...
Lärosäte
Uppsala universitet (4)
Stockholms universitet (2)
Karolinska Institutet (2)
Göteborgs universitet (1)
Luleå tekniska universitet (1)
Högskolan i Halmstad (1)
visa fler...
Lunds universitet (1)
Chalmers tekniska högskola (1)
visa färre...
Språk
Engelska (5)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (3)
Medicin och hälsovetenskap (2)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy